31 Jan 2018

UCB and investor syndicate led by Novo Seeds launch Syndesi Therapeutics to develop novel therapeutics for cognitive disorders

Read More
29 Jan 2018

Transparency Notification 

Read More
8 Jan 2018

CIMZIA® (certolizumab pegol) label change marks important advance for European women of childbearing age with chronic rheumatic disease

Read More
8 Jan 2018

European Medicines Agency Accepts Filing for EVENITY™ (romosozumab) 

Read More
19 Dec 2017

Bimekizumab demonstrates impressive joint and skin responses for psoriatic arthritis patients 

Read More
13 Dec 2017

Bimekizumab advances with significant results in ankylosing spondylitis patients

Read More
30 Nov 2017

UCB showcases new research and continued epilepsy leadership at the 2017 American Epilepsy Society Annual Meeting

Read More
7 Nov 2017

New study data shows prior osteoporotic fractures put women at increased risk of future major osteoporotic fractures

Read More
6 Nov 2017

Dermira and UCB Agree to End Collaboration Agreement for CIMZIA 

Read More
5 Nov 2017

UCB’s VIMPAT® (lacosamide) now approved by FDA to treat partial-onset seizures in pediatric epilepsy patients 

Read More
Subscribe to